Loading the security page…
NYSE American · PLX
Prices delayed by 15 minutes · 11 November 2026
The series is stated in the current share scale after splits; dividends are not included in the price
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Protalix BioTherapeutics, Inc. (DE) (PLX) is a company in the Health care sector; its shares trade on NYSE American.
The price of Protalix BioTherapeutics, Inc. (DE) (PLX) on November 11, 2026 is 3.04 $, +6.47 % on the day. Over 52 weeks the stock traded between 1.65 $ and 3.19 $; the price now sits 91 % of the way up that range. Over the past year the price changed by +5.46 %. The P/E ratio is 11.97, which is below the sector median (25.82). Market capitalization is 226.70 million $, rank 67 among 134 stocks of the same industry with a known capitalization.
Protalix BioTherapeutics, Inc. (DE) trades on NYSE American under the ticker PLX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PLX has traded between 1.65 $ and 3.19 $. As of 11 November 2026 the price stood 55.84% of the way from the 52-week low to the high.
Over one year PLX shares rose 5.46%; over six months they rose 26.77%. Volatility over 90 days is 42.62%. Dividends are not included: this is price change only, as of 11 November 2026.
PLX trades at a price-to-earnings ratio of 12.0, below the sector median of 25.8. Price to sales is 2.8, below the sector median of 3.7. Price to book is 3.2, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Protalix BioTherapeutics, Inc. (DE) reported revenue of 81M $ and net income of 19M $ over the last four quarters. Net margin is 23.50%. Revenue changed by +30.14% year over year. Earnings per share are $0.23. Market capitalisation is 227M $.
PLX has a return on equity of 26.53%, above the sector median of −40.58%. Return on assets is 17.17%, above the sector median of −30.08%. Operating margin is 28.89%, above the sector median of −20.96%.